Add to ORKGIn this original editorial piece, María Vallet-Regí, Patricia Mora-Raimundo, Daniel Lozano and Miguel Manzano (all at the Universidad Complutense de Madrid, Spain) discuss the use of nanoparticles for the potential treatment of osteoporosis, in light of some of their recently published work in the field
Osteoarthritis (OA) is a common chronic joint pathology that has become a predominant cause of disab...
Tissue engineering (TE) envisions the creation of functional substitutes for damaged tissues through...
[Introduction] Current treatments for osteogenic disorders are often successful, however they are no...
Osteoporosis is by far the most frequent metabolic disease affecting bone. Current clinical therapeu...
Osteoporosis is a degenerative bone disease commonly related to aging. With an increase in life expe...
Bone diseases include a wide group of skeletal-related disorders that cause mobility limitations and...
The introduction of nanoparticles into bone tissue engineering strategies is beneficial to govern ce...
Bone diseases, such as bone cancer, bone infection and osteoporosis, constitute a major issue for mo...
Abstract Nanotechnology changed the concept of treatment for a variety of diseases, producing a huge...
The osteogenic capability of mesoporous bioactive nanoparticles (MBNPs) in the SiO2–CaO system has b...
Nanotechnology is a vigorous research area and one of its important applications is in biomedical sc...
Osteoporosis is a serious public health problem affecting hundreds of millions of aged people worldw...
The overall objective of this PhD thesis has been the design of mesoporous nanoparticles for biomedi...
The application of nanotechnology in medicine, diagnostics, therapeutics, drug delivery, etc. in ord...
International audiencePurpose: Healing of osteoporotic defects is challenging and requires innovativ...
Osteoarthritis (OA) is a common chronic joint pathology that has become a predominant cause of disab...
Tissue engineering (TE) envisions the creation of functional substitutes for damaged tissues through...
[Introduction] Current treatments for osteogenic disorders are often successful, however they are no...
Osteoporosis is by far the most frequent metabolic disease affecting bone. Current clinical therapeu...
Osteoporosis is a degenerative bone disease commonly related to aging. With an increase in life expe...
Bone diseases include a wide group of skeletal-related disorders that cause mobility limitations and...
The introduction of nanoparticles into bone tissue engineering strategies is beneficial to govern ce...
Bone diseases, such as bone cancer, bone infection and osteoporosis, constitute a major issue for mo...
Abstract Nanotechnology changed the concept of treatment for a variety of diseases, producing a huge...
The osteogenic capability of mesoporous bioactive nanoparticles (MBNPs) in the SiO2–CaO system has b...
Nanotechnology is a vigorous research area and one of its important applications is in biomedical sc...
Osteoporosis is a serious public health problem affecting hundreds of millions of aged people worldw...
The overall objective of this PhD thesis has been the design of mesoporous nanoparticles for biomedi...
The application of nanotechnology in medicine, diagnostics, therapeutics, drug delivery, etc. in ord...
International audiencePurpose: Healing of osteoporotic defects is challenging and requires innovativ...
Osteoarthritis (OA) is a common chronic joint pathology that has become a predominant cause of disab...
Tissue engineering (TE) envisions the creation of functional substitutes for damaged tissues through...
[Introduction] Current treatments for osteogenic disorders are often successful, however they are no...